Ang-1 levels were 26% and Ang-2 levels were 44% higher in serum samples of ovarian carcinoma patients compared to normal controls (P < 0.05 and P < 0.01, respectively) (Table 1, Figure 1A). The gene discussed is ANGPT2; the disease is ovarian carcinoma.